PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 93 filers reported holding PMV PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $52,245 | -34.9% | 8,509 | -33.7% | 0.00% | – |
| Q2 2023 | $80,310 | -46.9% | 12,829 | -59.5% | 0.00% | – |
| Q1 2023 | $151,195 | -46.6% | 31,697 | -2.6% | 0.00% | – |
| Q4 2022 | $283,002 | -26.1% | 32,529 | +1.1% | 0.00% | -100.0% |
| Q3 2022 | $383,000 | -18.5% | 32,186 | -2.3% | 0.00% | 0.0% |
| Q2 2022 | $470,000 | +8.3% | 32,960 | +58.1% | 0.00% | 0.0% |
| Q1 2022 | $434,000 | -20.8% | 20,847 | -12.1% | 0.00% | 0.0% |
| Q4 2021 | $548,000 | -21.3% | 23,727 | +1.6% | 0.00% | 0.0% |
| Q3 2021 | $696,000 | -43.6% | 23,362 | -35.4% | 0.00% | -50.0% |
| Q2 2021 | $1,235,000 | +81.6% | 36,166 | +75.0% | 0.00% | +100.0% |
| Q1 2021 | $680,000 | -46.5% | 20,662 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $1,271,000 | – | 20,662 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $23,012,000 | 42.78% |
| Euclidean Capital LLC | 2,336,909 | $33,301,000 | 28.32% |
| OUP Management Co., LLC | 989,232 | $14,097,000 | 19.40% |
| Nextech Invest Ltd. | 1,385,807 | $19,748,000 | 6.66% |
| Boxer Capital, LLC | 3,498,636 | $49,856,000 | 3.16% |
| PERSONAL CFO SOLUTIONS, LLC | 550,342 | $7,842,000 | 1.84% |
| Orbimed Advisors | 6,563,077 | $93,524,000 | 1.70% |
| RTW INVESTMENTS, LP | 4,395,677 | $62,638,000 | 1.62% |
| ACUTA CAPITAL PARTNERS, LLC | 152,500 | $2,173,000 | 1.21% |
| Avoro Capital Advisors LLC | 3,100,000 | $44,175,000 | 0.87% |